Recursion Pharmaceuticals, Inc. RXRX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax by Product | ||||||
| Grant revenue | $670K+2,780% | $426K+21.4% | $274K-53.0% | $82K-91.9% | -$25K-102% | |
| Operating revenue | $65.74M+9.9% | $74.26M+27.0% | $43.42M-32.8% | $64.51M+32.7% | $59.82M+32.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Recursion Pharmaceuticals, Inc. break its business down?
- Recursion Pharmaceuticals, Inc. (RXRX) reports revenue from contract with customer, excluding assessed tax by product across 2 parts — Grant revenue and Operating revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Recursion Pharmaceuticals, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Recursion Pharmaceuticals, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
